Product Information
TYBLUME 0.1-0.02 MG CHEW TAB is a brand product labeled by Exeltis USA, Inc., priced at $0.8277 per EA under NDC 00642747101. Its NADAC has been published 184 times since Dec 21, 2022.
Manufacturer
Exeltis USA, Inc.NDC
00642747101
Classification
Brand
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
New Drug (NDA)
FDA Application
NDA209405On Market Since
10/26/2020
Price Statistics
The NADAC for TYBLUME 0.1-0.02 MG CHEW TAB has been published 184 times since Dec 21, 2022, and over the history we have for it it has risen 10.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8277 per EA |
|---|---|
| All-time high | $0.8277 (Jun 24, 2026) |
| All-time low | $0.7466 (Dec 21, 2022) |
| 52-week high | $0.8277 |
| 52-week low | $0.7518 |
| Median price | $0.7522 |
| Average price | $0.7615 |
| Largest weekly change | +10.0% (Dec 31, 2025) |
| Weeks tracked | 184 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 86% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TYBLUME 0.1-0.02 MG CHEW TAB?
The current National Average Drug Acquisition Cost (NADAC) for TYBLUME 0.1-0.02 MG CHEW TAB, manufactured by Exeltis USA, Inc., is $0.8277 per EA (NDC 00642747101), effective Jun 24, 2026.
How has the price of TYBLUME 0.1-0.02 MG CHEW TAB changed over time?
Over the history we have for it, the NADAC for TYBLUME 0.1-0.02 MG CHEW TAB has risen 10.9%. It has been tracked across 184 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for TYBLUME 0.1-0.02 MG CHEW TAB?
Since Dec 21, 2022, the NADAC for TYBLUME 0.1-0.02 MG CHEW TAB has ranged from a low of $0.7466 (Dec 21, 2022) to a high of $0.8277 (Jun 24, 2026), with a median of $0.7522 per EA.
Are there cheaper alternatives to TYBLUME 0.1-0.02 MG CHEW TAB?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1125 per EA — about 86% below TYBLUME 0.1-0.02 MG CHEW TAB.
Who manufactures TYBLUME 0.1-0.02 MG CHEW TAB?
TYBLUME 0.1-0.02 MG CHEW TAB (NDC 00642747101) is labeled by Exeltis USA, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification